+44 (0) 20 7079 4399
Call HCA from 8am-8pm Mon-Fri and 9am-5pm Sat
HCA Healthcare UK
Professor Michael Hanna
BSc(Hons), MBChB(Hons), MD, FRCP(UK)
Rehabilitation, Headaches, Muscle Weakness, Epilepsy and Stroke
National Hospital for Neurolog
Professor Michael Hanna is a Consultant Neurologist and Director of the Queen Square Division of UCLH NHS Trust co-leading a team overseeing 1000 staff and a clinical budget of 134m. He runs the Queen Square clinical centre for patients with genetic and acquired muscle disease which includes two nationally commissioned services funded directly by the Department of health 1.5m pa for mitochondrial disease and for neurological channelopathies. Professor Hanna is the Director of the recently established MRC Centre for translational research in neuromuscular disease 2008 3.4m. This new MRC Centre aims to link basic science advances to clinical trials in patients with progressive muscle wasting neuromuscular diseases including muscular dystrophy, inflammatory myopathies, neuropathies and motor neuron diseases. This centre has established new core activities including neuromuscular clinical trials, translational science PhD programmme, neuromuscular biobanking and neuromuscular MRI. Professor Hanna has recently successfully lead a major fund raising initiative delivering a 2m state of the art neuromuscular clinical trials centre for neuromuscular diseases at Queen Square (April 2009); which will be the hub of all neuromuscular clinical trials activity. He has published over 150 peer reviewed original research papers including New England Journal of Medicine and Lancet. He has raised over 6m external research funding in the last four years in genetic and clinical research including in neurological channelopathies and in mitochondrial disease.
Call the contact centre
+44 (0) 20 7079 4399
8am-8pm Mon-Fri, 9am-5pm Sat
Let us call you backCan we call you back at a more convenient time
Email contact centreSend us an email and we will get back to you.
© copyright 2008 - 2017 HCA Healthcare UK.
Registered Name: HCA International Limited; The part of the UK in which it is registered: England and Wales;
Registered Number: 03020522; Registered Office Address: 242 Marylebone Road London NW1 6JL.
£500m has been invested by HCA International in the latest medical technologies and facilities over the last 10 years.
Your hospital will be one of our world-class private hospitals: HCA’s world-class hospitals are accredited by The CHKS Accreditation Unit, a leading provider of healthcare intelligence and quality improvement services. The accreditation is a measure of the overall quality of a hospital and hospitals with CHKS accreditation have been shown to provide a better quality of service.
Your safety will be protected because we have more critical care beds than any other private hospital group: HCA hospitals achieved 100% compliance with all Care Quality Commission inspected outcomes of care in 2011.
Your treatment will be undertaken using the most advanced diagnostic and treatment facilities: Oliver Wyman, Corporate Accounts: Driving quality and value, January 2012.